EVERETT, Wash. — The Everett Fire Department’s Emergency Medical Services Division (EMS) has launched a new pilot programto allow paramedics to administer buprenorphine, to help with opiate withdrawal ...

Opioid withdrawal can consist of different symptoms at varying severities. Calculating an opioid withdrawal score provides insight for your doctor when it comes to customizing your treatment and ...

Add Yahoo as a preferred source to see more of our stories on Google. Students perform yoga inside a college campus during International Yoga Day in Mumbai, India, June 21, 2022. REUTERS/Francis ...

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

Third-party research groups and organizations have validated a smartphone app called Reflex as a tool to help diagnose medical conditions like concussions and opiate withdrawal. Brightlamp CEO Kurtis ...

BioXcel Therapeutics Inc. BTAI shares are up during Thursday’s premarket session following positive topline results from a Phase 2 study evaluating BXCL501 for treating opioid withdrawal symptoms. The ...

This is the second post in a series on non-medication approaches for alcohol and drug abuse. Opioid addiction is a public health crisis in the U.S. It is estimated that as many as 36 million Americans ...

Share on Pinterest CBD derivatives showed promise in supplementing the opioid overdose drug naloxone. Micky Wiswedel/Stocksy United Researchers are studying how specific components of cannabidiol (CBD ...

Chicago, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The global opioid withdrawal syndrome (OWS) market was valued at 1,068.3 million in 2021 and is expected to reach US$ 2,633.4 million by 2030, growing at a ...

Founded in 2015, Sanford Behavioral Health is licensed and accredited as a substance use disorder, eating disorder, and co-occurring mental health treatment facility, serving Michigan and beyond.

SEATTLE--(BUSINESS WIRE)--Proniras Corporation (“Proniras”), a clinical-stage biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty ...

Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...